Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
The safety and efficacy of the clonidine patch are contingent on the integrity of the transdermal system and the condition of the dermal surface to which it is applied. This article presents the first 2 case reports in the literature of unintentional overdose in pediatric patients with attention-deficit/hyperactivity disorder treated with transdermal clonidine. Appropriate precautions and patient education can help limit toxicity from the clonidine patch in children and adolescents.
Broderick-Cantwell
J J
JJ
University of Colorado School of Medicine, Denver, USA.
D000279:Administration, Cutaneous; D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000506:poisoning*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002648:Child; D003000:Clonidine / Q000008:administration & dosage / Q000506:poisoning*; D062787:Drug Overdose; D006801:Humans; D008297:Male
D000316:Adrenergic alpha-Agonists; D003000:Clonidine